Abstract: A facility applies a received query containing identifying information for a person to both (1) first accounts in a first information system each authorizing access to a resource among a set, to obtain a first result identifying any matching first accounts; and (2) second accounts in a second information system that each authorize access to a resource among the set, to obtain a second result identifying any matching second accounts. For each resource of the set whose access is authorized by at least one identified first account or one identified second account, the facility creates an entry representing any identified first account authorizing access to the resource and any identified second account authorizing access to the resource. The facility causes the created entries to be displayed, and solicits input selecting a displayed entry for administrative action with respect to at least one of the accounts it represents.

Abstract: The present disclosure provides extracellular vesicle-enriched compositions derived from iPSC-derived microglia. Further provided herein are methods for using the extracellular vesicle-enriched compositions from iPSC-derived microglia in screening assays to discover properties, including therapeutic properties.

Abstract: The present disclosure provides methods for maturing hepatocytes comprising culturing with cyclic adenosine monophosphate and a Janus kinase inhibitor. There is also provided a method for screening inhibitors of hepatitis B virus infection and/or replication.

Abstract: Provided herein are methods for the generation of functional keratinocyte stem cells that are differentiated directly from human ESCs/iPSCs in a chemically defined serum-free cell culture system, as well as cells derived therefrom and methods of use thereof. Also provided are methods for culturing primary keratinocytes.

Abstract: The present disclosure provides methods for maturing hepatocytes comprising culturing with cyclic adenosine monophosphate and a Janus kinase inhibitor. There is also provided a method for screening inhibitors of hepatitis B virus infection and/or replication.

Abstract: Provided herein are methods for the generation of functional keratinocyte stem cells that are differentiated directly from human ESCs/iPSCs in a chemically defined serum-free cell culture system, as well as cells derived therefrom and methods of use thereof. Also provided are methods for culturing primary keratinocytes.